Related Experiment Video
Updated: Jul 6, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
[The gut microbiome in Parkinson's disease]
J R Bedarf1,2, F Hildebrand3, F Goeser4,5
1Klinik und Poliklinik für Neurologie, Universitätsklinikum Bonn, Sigmund-Freud-Straße 25, 53127, Bonn, Deutschland. janis.bedarf@ukbonn.de.
Abstract:
The vast majority of Parkinson's disease (PD) cases are of sporadic origin and despite extensive research in recent years, the etiology still remains unclear. Several current case control studies are aiming to characterize a putative PD-specific composition of the gut microbiome, reflecting the potential relevance of microbiota in the pathogenesis of PD. Although methodologies and cohort sizes differed, the currently available studies showed reproducible or consistent results in terms of PD-specific alterations to the intestinal bacteria. By applying metagenomic sequencing procedures, it is even possible to distinguish PD cases from healthy individuals at a very early disease stage by means of individually modified microbiota. Among others, microbiota that are associated with an altered intestinal barrier or immune function, such as Akkermansia, Lactobacillus, Faecalibacterium and Prevotella were significantly over-represented or under-represented. There may even be a prodromal microbiome, as a comparable microbial shift is also found in patients with rapid eye movement (REM) sleep behavior disorder (RBD), a risk factor for the later development of synucleinopathies, such as PD.
Insights
Parkinson's disease (PD) gut microbiome alterations are detectable even in early stages. Specific bacterial shifts in Parkinson's patients may indicate disease progression and potential diagnostic markers.
Area of Science:
- Microbiology
- Neurology
- Gastroenterology
Background:
- The etiology of sporadic Parkinson's disease (PD) remains largely unknown.
- Gut microbiome alterations are increasingly implicated in PD pathogenesis.
- Previous studies suggest PD-specific changes in intestinal bacteria.
Purpose of the Study:
- To characterize the gut microbiome composition in Parkinson's disease.
- To investigate the potential of the gut microbiome as an early diagnostic marker for PD.
- To explore the link between gut microbiota and prodromal PD symptoms.
Main Methods:
- Metagenomic sequencing of gut microbiota in PD patients and healthy controls.
- Comparative analysis of bacterial composition between groups.
- Identification of specific bacterial taxa associated with PD.
Main Results:
- Consistent PD-specific alterations in gut bacterial composition were observed across studies.
- Metagenomic sequencing can distinguish early-stage PD patients from healthy individuals based on their microbiota.
- Specific bacteria, including Akkermansia, Lactobacillus, Faecalibacterium, and Prevotella, were significantly altered in PD patients.
- Similar microbial shifts were found in patients with REM sleep behavior disorder (RBD), a PD risk factor.
Conclusions:
- The gut microbiome plays a significant role in Parkinson's disease pathogenesis.
- Gut microbiota profiling shows potential for early PD diagnosis and risk assessment.
- Prodromal microbiome changes may precede synucleinopathy development, as indicated by RBD findings.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Dysbiosis of the Gut Microbiota
Gut-Brain Axis
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology

